Greenfield Savings Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
868
-5
-0.6% -$5.11K 0.39% 64
2026
Q1
$803K Buy
873
+5
+0.6% +$5.07K 0.34% 77
2025
Q4
$933K Buy
868
+8
+0.9% +$7.65K 0.39% 64
2025
Q3
$656K Sell
860
-1
-0.1% -$744 0.28% 89
2025
Q2
$671K Buy
861
+4
+0.5% +$3.11K 0.3% 83
2025
Q1
$708K Buy
857
+12
+1% +$9.98K 0.35% 80
2024
Q4
$652K Buy
845
+5
+0.6% +$4.14K 0.31% 84
2024
Q3
$744K Hold
840
0.35% 76
2024
Q2
$761K Buy
840
+5
+0.6% +$4K 0.39% 73
2024
Q1
$650K Hold
835
0.34% 79
2023
Q4
$487K Sell
835
-10
-1% -$5.84K 0.28% 91
2023
Q3
$454K Buy
+845
New +$435K 0.28% 93
2023
Q2
Sell
-704
Closed -$242K 140
2023
Q1
$242K Hold
704
0.16% 118
2022
Q4
$258K Sell
704
-25
-3% -$8.86K 0.17% 117
2022
Q3
$236K Hold
729
0.17% 118
2022
Q2
$236K Buy
+729
New +$219K 0.16% 125

Other funds holding LLY

Greenfield Savings Bank's LLY Position: Q2 2026 in Review

Greenfield Savings Bank reduced its Eli Lilly (LLY) stake by 0.57% in Q2 2026, selling an estimated $5.11K and leaving 868 shares worth $1.04M. The position accounts for 0.39% of the portfolio, ranked #64.

Greenfield Savings Bank first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Greenfield Savings Bank held 868 shares of Eli Lilly worth $1.04M as of Q2 2026.
  • Greenfield Savings Bank sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.39% of Greenfield Savings Bank's portfolio in Q2 2026, its #64 holding.
  • Greenfield Savings Bank first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Greenfield Savings Bank's 13F filing for Q2 2026, filed 7 Jul 2026.